Industry: Chemical & Material
Published Date: 2025-01-16
Pages: 122 Pages
Report ld: 3475736
Request Sample
Customized Report
Chitosan Derivatives Market Size(US$)

CAGR 2025-2031
6.2%
Market Size,2031
USD 78.5
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Chitosan Derivatives was estimated to be worth US$ 51.8 million in 2024 and is forecast to a readjusted size of US$ 78.5 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Chitosan is a linear polysaccharide composed of randomly distributed β-(1-4)-linked D-glucosamine and N-acetyl-D-glucosamine. It is produced by basic (caustic soda) deacetylation reaction of chitin, the main component of fungi cell walls and insect or crustacean exoskeletons.
The major players in global Chitosan Derivatives market include Golden-Shell, Lushen Bioengineering, AK BIOTECH, etc. The top 3 players occupy about 30% shares of the global market. China is the main market, and occupies about 50% of the global market. Chitosan HCl is the main type, with a share about 45%. Medical is the main application, which holds a share about 40%.
This report aims to provide a comprehensive presentation of the global market for Chitosan Derivatives, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Chitosan Derivatives by region & country, by Type, and by Application.
The Chitosan Derivatives market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chitosan Derivatives.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Chitosan Derivatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Chitosan Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Chitosan Derivatives in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Chitosan Derivatives Product Introduction
1.2 Global Chitosan Derivatives Market Size Forecast
1.2.1 Global Chitosan Derivatives Sales Value (2020-2031)
1.2.2 Global Chitosan Derivatives Sales Volume (2020-2031)
1.2.3 Global Chitosan Derivatives Sales Price (2020-2031)
1.3 Chitosan Derivatives Market Trends & Drivers
1.3.1 Chitosan Derivatives Industry Trends
1.3.2 Chitosan Derivatives Market Drivers & Opportunity
1.3.3 Chitosan Derivatives Market Challenges
1.3.4 Chitosan Derivatives Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Chitosan Derivatives Players Revenue Ranking (2024)
2.2 Global Chitosan Derivatives Revenue by Company (2020-2025)
2.3 Global Chitosan Derivatives Players Sales Volume Ranking (2024)
2.4 Global Chitosan Derivatives Sales Volume by Company Players (2020-2025)
2.5 Global Chitosan Derivatives Average Price by Company (2020-2025)
2.6 Key Manufacturers Chitosan Derivatives Manufacturing Base and Headquarters
2.7 Key Manufacturers Chitosan Derivatives Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Chitosan Derivatives
2.9 Chitosan Derivatives Market Competitive Analysis
2.9.1 Chitosan Derivatives Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Chitosan Derivatives Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chitosan Derivatives as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chitosan HCl
3.1.2 Carboxymethyl Chitosan
3.1.3 Chitosan Quaternary Ammonium Salt
3.1.4 Hydroxypropyl Chitosan
3.1.5 Chitosan Oligosaccharide
3.1.6 Others
3.2 Global Chitosan Derivatives Sales Value by Type
3.2.1 Global Chitosan Derivatives Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Chitosan Derivatives Sales Value, by Type (2020-2031)
3.2.3 Global Chitosan Derivatives Sales Value, by Type (%) (2020-2031)
3.3 Global Chitosan Derivatives Sales Volume by Type
3.3.1 Global Chitosan Derivatives Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Chitosan Derivatives Sales Volume, by Type (2020-2031)
3.3.3 Global Chitosan Derivatives Sales Volume, by Type (%) (2020-2031)
3.4 Global Chitosan Derivatives Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical
4.1.2 Health Food
4.1.3 Cosmetics
4.1.4 Water Treatment
4.1.5 Others
4.2 Global Chitosan Derivatives Sales Value by Application
4.2.1 Global Chitosan Derivatives Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Chitosan Derivatives Sales Value, by Application (2020-2031)
4.2.3 Global Chitosan Derivatives Sales Value, by Application (%) (2020-2031)
4.3 Global Chitosan Derivatives Sales Volume by Application
4.3.1 Global Chitosan Derivatives Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Chitosan Derivatives Sales Volume, by Application (2020-2031)
4.3.3 Global Chitosan Derivatives Sales Volume, by Application (%) (2020-2031)
4.4 Global Chitosan Derivatives Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Chitosan Derivatives Sales Value by Region
5.1.1 Global Chitosan Derivatives Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Chitosan Derivatives Sales Value by Region (2020-2025)
5.1.3 Global Chitosan Derivatives Sales Value by Region (2026-2031)
5.1.4 Global Chitosan Derivatives Sales Value by Region (%), (2020-2031)
5.2 Global Chitosan Derivatives Sales Volume by Region
5.2.1 Global Chitosan Derivatives Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Chitosan Derivatives Sales Volume by Region (2020-2025)
5.2.3 Global Chitosan Derivatives Sales Volume by Region (2026-2031)
5.2.4 Global Chitosan Derivatives Sales Volume by Region (%), (2020-2031)
5.3 Global Chitosan Derivatives Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Chitosan Derivatives Sales Value, 2020-2031
5.4.2 North America Chitosan Derivatives Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Chitosan Derivatives Sales Value, 2020-2031
5.5.2 Europe Chitosan Derivatives Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Chitosan Derivatives Sales Value, 2020-2031
5.6.2 Asia Pacific Chitosan Derivatives Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Chitosan Derivatives Sales Value, 2020-2031
5.7.2 South America Chitosan Derivatives Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Chitosan Derivatives Sales Value, 2020-2031
5.8.2 Middle East & Africa Chitosan Derivatives Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Chitosan Derivatives Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Chitosan Derivatives Sales Value
6.2.1 Key Countries/Regions Chitosan Derivatives Sales Value, 2020-2031
6.2.2 Key Countries/Regions Chitosan Derivatives Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Chitosan Derivatives Sales Value, 2020-2031
6.3.2 United States Chitosan Derivatives Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Chitosan Derivatives Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Chitosan Derivatives Sales Value, 2020-2031
6.4.2 Europe Chitosan Derivatives Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Chitosan Derivatives Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Chitosan Derivatives Sales Value, 2020-2031
6.5.2 China Chitosan Derivatives Sales Value by Type (%), 2024 VS 2031
6.5.3 China Chitosan Derivatives Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Chitosan Derivatives Sales Value, 2020-2031
6.6.2 Japan Chitosan Derivatives Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Chitosan Derivatives Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Chitosan Derivatives Sales Value, 2020-2031
6.7.2 South Korea Chitosan Derivatives Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Chitosan Derivatives Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Chitosan Derivatives Sales Value, 2020-2031
6.8.2 Southeast Asia Chitosan Derivatives Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Chitosan Derivatives Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Chitosan Derivatives Sales Value, 2020-2031
6.9.2 India Chitosan Derivatives Sales Value by Type (%), 2024 VS 2031
6.9.3 India Chitosan Derivatives Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 FMC Corp
7.1.1 FMC Corp Company Information
7.1.2 FMC Corp Introduction and Business Overview
7.1.3 FMC Corp Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 FMC Corp Chitosan Derivatives Product Offerings
7.1.5 FMC Corp Recent Development
7.2 Kitozyme
7.2.1 Kitozyme Company Information
7.2.2 Kitozyme Introduction and Business Overview
7.2.3 Kitozyme Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Kitozyme Chitosan Derivatives Product Offerings
7.2.5 Kitozyme Recent Development
7.3 Kunpoong Bio
7.3.1 Kunpoong Bio Company Information
7.3.2 Kunpoong Bio Introduction and Business Overview
7.3.3 Kunpoong Bio Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Kunpoong Bio Chitosan Derivatives Product Offerings
7.3.5 Kunpoong Bio Recent Development
7.4 BIO21
7.4.1 BIO21 Company Information
7.4.2 BIO21 Introduction and Business Overview
7.4.3 BIO21 Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 BIO21 Chitosan Derivatives Product Offerings
7.4.5 BIO21 Recent Development
7.5 Heppe Medical Chitosan
7.5.1 Heppe Medical Chitosan Company Information
7.5.2 Heppe Medical Chitosan Introduction and Business Overview
7.5.3 Heppe Medical Chitosan Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Heppe Medical Chitosan Chitosan Derivatives Product Offerings
7.5.5 Heppe Medical Chitosan Recent Development
7.6 Yaizu Suisankagaku
7.6.1 Yaizu Suisankagaku Company Information
7.6.2 Yaizu Suisankagaku Introduction and Business Overview
7.6.3 Yaizu Suisankagaku Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Yaizu Suisankagaku Chitosan Derivatives Product Offerings
7.6.5 Yaizu Suisankagaku Recent Development
7.7 Golden-Shell
7.7.1 Golden-Shell Company Information
7.7.2 Golden-Shell Introduction and Business Overview
7.7.3 Golden-Shell Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Golden-Shell Chitosan Derivatives Product Offerings
7.7.5 Golden-Shell Recent Development
7.8 Lushen Bioengineering
7.8.1 Lushen Bioengineering Company Information
7.8.2 Lushen Bioengineering Introduction and Business Overview
7.8.3 Lushen Bioengineering Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Lushen Bioengineering Chitosan Derivatives Product Offerings
7.8.5 Lushen Bioengineering Recent Development
7.9 AK BIOTECH
7.9.1 AK BIOTECH Company Information
7.9.2 AK BIOTECH Introduction and Business Overview
7.9.3 AK BIOTECH Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 AK BIOTECH Chitosan Derivatives Product Offerings
7.9.5 AK BIOTECH Recent Development
7.10 Zhejiang New Fuda Ocean Biotech
7.10.1 Zhejiang New Fuda Ocean Biotech Company Information
7.10.2 Zhejiang New Fuda Ocean Biotech Introduction and Business Overview
7.10.3 Zhejiang New Fuda Ocean Biotech Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Zhejiang New Fuda Ocean Biotech Chitosan Derivatives Product Offerings
7.10.5 Zhejiang New Fuda Ocean Biotech Recent Development
7.11 Weifang Sea Source Biological Products
7.11.1 Weifang Sea Source Biological Products Company Information
7.11.2 Weifang Sea Source Biological Products Introduction and Business Overview
7.11.3 Weifang Sea Source Biological Products Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Weifang Sea Source Biological Products Chitosan Derivatives Product Offerings
7.11.5 Weifang Sea Source Biological Products Recent Development
7.12 Qingdao Honghai Bio-tech
7.12.1 Qingdao Honghai Bio-tech Company Information
7.12.2 Qingdao Honghai Bio-tech Introduction and Business Overview
7.12.3 Qingdao Honghai Bio-tech Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Qingdao Honghai Bio-tech Chitosan Derivatives Product Offerings
7.12.5 Qingdao Honghai Bio-tech Recent Development
7.13 Haidebei Marine Bioengineering
7.13.1 Haidebei Marine Bioengineering Company Information
7.13.2 Haidebei Marine Bioengineering Introduction and Business Overview
7.13.3 Haidebei Marine Bioengineering Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Haidebei Marine Bioengineering Chitosan Derivatives Product Offerings
7.13.5 Haidebei Marine Bioengineering Recent Development
7.14 Jiangsu Aoxin Biotechnology
7.14.1 Jiangsu Aoxin Biotechnology Company Information
7.14.2 Jiangsu Aoxin Biotechnology Introduction and Business Overview
7.14.3 Jiangsu Aoxin Biotechnology Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Jiangsu Aoxin Biotechnology Chitosan Derivatives Product Offerings
7.14.5 Jiangsu Aoxin Biotechnology Recent Development
7.15 Jinhu Crust Product
7.15.1 Jinhu Crust Product Company Information
7.15.2 Jinhu Crust Product Introduction and Business Overview
7.15.3 Jinhu Crust Product Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Jinhu Crust Product Chitosan Derivatives Product Offerings
7.15.5 Jinhu Crust Product Recent Development
8 Industry Chain Analysis
8.1 Chitosan Derivatives Industrial Chain
8.2 Chitosan Derivatives Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Chitosan Derivatives Sales Model
8.5.2 Sales Channel
8.5.3 Chitosan Derivatives Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Chitosan Derivatives market size was US$ 54.72 million in 2025 and is forecast to reach a readjusted size of US$ 82.88 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 93
USD 4250.00
(Single User License)
The global Chitosan Derivatives market was valued at US$ 54.72 million in 2025 and is anticipated to reach US$ 82.88 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 142
USD 2900.00
(Single User License)
The global market for Chitosan Derivatives was estimated to be worth US$ 54.72 million in 2025 and is projected to reach US$ 82.88 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 130
USD 3950.00
(Single User License)
The global Chitosan Derivatives market is projected to grow from US$ 51.8 million in 2024 to US$ 78.5 million by 2031, at a CAGR of 6.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 158
USD 4900.00
(Single User License)
The global Chitosan Derivatives market is projected to grow from US$ 54.7 million in 2025 to US$ 78.5 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.
Published Date: 2025-06-14
Pages: 152
USD 4900.00
(Single User License)
The global market for Chitosan Derivatives was estimated to be worth US$ 51.8 million in 2024 and is forecast to a readjusted size of US$ 78.5 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-06-14
Pages: 116
USD 3950.00
(Single User License)
The global Chitosan Derivatives market size was US$ 51.8 million in 2024 and is forecast to a readjusted size of US$ 78.5 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-06-14
Pages: 96
USD 4250.00
(Single User License)
The global market for Chitosan Derivatives was valued at US$ 51.8 million in the year 2024 and is projected to reach a revised size of US$ 78.5 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published Date: 2025-06-14
Pages: 104
USD 2900.00
(Single User License)
In 2024, the global market size of Chitosan Derivatives was estimated to be worth US$ 51.8 million and is forecast to reach approximately US$ 78.5 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 144
USD 5900.00
(Single User License)
Chitosan is a linear polysaccharide composed of randomly distributed β-(1-4)-linked D-glucosamine and N-acetyl-D-glucosamine. It is produced by basic (caustic soda) deacetylation reaction of chitin, the main component of fungi cell walls and insect or crustacean exoskeletons.
Published Date: 2024-04-17
Pages: 187
USD 5600.00
(Single User License)
The global Chitosan Derivatives market size was US$ 54.72 million in 2025 and is forecast to reach a readjusted size of US$ 82.88 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 93
The global Chitosan Derivatives market was valued at US$ 54.72 million in 2025 and is anticipated to reach US$ 82.88 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 142
The global market for Chitosan Derivatives was estimated to be worth US$ 54.72 million in 2025 and is projected to reach US$ 82.88 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 130
The global Chitosan Derivatives market is projected to grow from US$ 51.8 million in 2024 to US$ 78.5 million by 2031, at a CAGR of 6.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 158
The global Chitosan Derivatives market is projected to grow from US$ 54.7 million in 2025 to US$ 78.5 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.
Published: 2025-06-14
Pages: 152
The global market for Chitosan Derivatives was estimated to be worth US$ 51.8 million in 2024 and is forecast to a readjusted size of US$ 78.5 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-06-14
Pages: 116
The global Chitosan Derivatives market size was US$ 51.8 million in 2024 and is forecast to a readjusted size of US$ 78.5 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-06-14
Pages: 96
The global market for Chitosan Derivatives was valued at US$ 51.8 million in the year 2024 and is projected to reach a revised size of US$ 78.5 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published: 2025-06-14
Pages: 104
In 2024, the global market size of Chitosan Derivatives was estimated to be worth US$ 51.8 million and is forecast to reach approximately US$ 78.5 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 144
Chitosan is a linear polysaccharide composed of randomly distributed β-(1-4)-linked D-glucosamine and N-acetyl-D-glucosamine. It is produced by basic (caustic soda) deacetylation reaction of chitin, the main component of fungi cell walls and insect or crustacean exoskeletons.
Published: 2024-04-17
Pages: 187
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now